Just wanted to update everyone on Dr. Czerniecki's DCIS/Her2/neu vaccine trial at P\University of Pennsylvania. I ask him and he told me he is seeing immune response in 90% of trial patients, 40% of them have complete response (immune response plus tumor area gone). Also in the group given the vaccine that is Er and Pr receptor negative and Her2/neu positive (G=20) there have been NO recurrences! So please let everyone find out about this trial who might be eligible (DCIS and Positive for Her2/neu regardless of ER and Pr receptor status) I was one of the lucky ones who GOT the vaccine. Website
www.shelleydodt.com.